No-see policies leave many physicians in the dark about formularies and medication benefits
A study sponsored jointly by Quantia Inc. and Capgemini Consulting points out a well-known gap in communications with prescribers: fewer and fewer of them are being visited by reps. But according to respondents (some 3,000 physicians who interacted with an online survey), physicians employed at what the sponsors call “organized provider systems” (OPSs, integrated delivery networks, hospital systems, accountable care organizations and the like), they also have too little communication with their own management, especially when it comes to who is making formulary decisions within the network, or why. About a third of physicians don’t know their systems’ reimbursement models; and four out of five physicians do not receive any information about drug cost-effectiveness, or who is making formulary decisions that, in many cases, dictate which drugs can be prescribed. (the survey also shows that 10% of respondents can only prescribe on formulary for out-patient service, and 22% for in-patient service; higher percentages of respondents can choose among alternatives on the formulary—with authorization.)
The survey found that the percentage of “no see” physicians (whether at an OPS or not) has jumped from 27 to 32% in the past year, and that 42% of those working within OPSs never see a rep, usually because of OPN policy. And since younger physicians (less than 10 years after medical school) are almost exclusively joining OPNs, the trends are only going to worsen.
Meanwhile, respondents both want more medical education from the pharma industry, and complain that insufficient support is available. Some 41% of them want more provider/staff education, but only 16% believe the pharma industry is currently addressing this. And 90% feel that partnerships with pharma—for services like patient support, pathway development or quality improvement programs—would improve the quality of care. (Meanwhile, when the responses are split between physician-level and OPS-executive level, only 2% of executives feel that provider/staff education is worth pursuing.)
Quantia, a provider of a popular online community for physicians, QuantiaMD, along with Capgemini, see the use of digital media as a means to connect with prescribing physicians directly, and to provide education and other services. Pharma marketers should “support the field force with resources that supplement basic clinical and market access messaging with topics such as protocol selection impact modeling, disease education, care coordination, and quality improvement initiatives.”
The study, “Working the System: 4 Trends Driving New Opportunities for Engaging Physicians in Organized Provider Systems,” is available here.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.